J.B. Chemicals & Pharmaceuticals Lt (Delisted) share news and announcements

BSE: 506943Pharmaceuticals & Biotechnology

Last traded ₹2,408.90 on 16 Jul 2026

Delisted on 12 Oct 2026.

J.B. Chemicals & Pharmaceuticals Lt share news and announcements

1,922 announcements, routine notices left out, newest first. Page 2 of 39.

Mar 2026
- 25 Mar · Disclosure of material issue
  JB Chemicals & Pharmaceuticals Limited has informed regarding Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in relation to Scheme of Amalgamation (opens in a new tab)
- 25 Mar · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in relation to Scheme of Amalgamation (opens in a new tab)
- 24 Mar · Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in relation to Scheme of Amalgamation (opens in a new tab)
- 24 Mar · Disclosure of material issue
  JB Chemicals & Pharmaceuticals Limited has informed regarding Disclosure under Regulation 30 in relation to Scheme of Amalgamation (opens in a new tab)
- 24 Mar · Management
  Outcome of Postal Ballot - Appointment of Directors (opens in a new tab)
- 24 Mar · Meeting
  Result of Postal Ballot (opens in a new tab)
- 24 Mar · Meeting
  Copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. (opens in a new tab)
- 24 Mar · Management
  Change in Director(s) of the company. (opens in a new tab)
- 24 Mar · Meeting
  Results of Postal Ballot (opens in a new tab)
- 19 Mar · Disclosure of material issue
  JB Chemicals & Pharmaceuticals Limited has informed regarding Disclosure under Regulation 30 (opens in a new tab)
- 19 Mar · Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
  Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 - Receipt of Order (opens in a new tab)
- 13 Mar · Management
  Resignation of Ms. Sushree Mishra as General Manager-Corporate Strategy, Communication and In-licensing of the Company w.e.f. March 13, 2026. (opens in a new tab)
- 13 Mar · Management
  Change in Senior Management Personnel (opens in a new tab)
- 11 Mar · Management
  Cessation of Mr. Jason D'souza as the Executive Vice President with effect from close of business hours on March 6, 2026 (opens in a new tab)
- 11 Mar · Management
  Resignation of Mr. Jason D souza as Executive Vice President of the Company w.e.f. March 06, 2026. (opens in a new tab)
- 10 Mar · Management
  Resignation of Mr. Jason D souza as Other of the company w.e.f. March 06, 2026. (opens in a new tab)
- 10 Mar · Management
  Resignation of Mr. Kunal Khanna and Mr. Dilip Singh Rathore as Other of the company w.e.f. March 05, 2026. (opens in a new tab)
- 10 Mar · Management
  Change in Senior Management Personnel - Letter of Resignation (opens in a new tab)
Feb 2026
- 20 Feb · Meeting
  Postal Ballot Notice (opens in a new tab)
- 20 Feb · Meeting
  Notice of Postal Ballot (opens in a new tab)
- 19 Feb · Disclosure
  This is to inform you that the Compensation Committee of the Board of Directors of the Company has, on February 19, 2026, allotted 31,160 fully paid up equity shares of Re. 1/- each of the Company, to one of the ESOP holder on exercise of stock options granted to him pursuant to JBCPL Employee Stock Option Scheme, 2021 (opens in a new tab)
- 19 Feb · Disclosure
  Allotment of Equity Shares on exercise of ESOPs (opens in a new tab)
- 7 Feb · Management
  Change in Senior Management Personnel - Resignation (opens in a new tab)
- 7 Feb · Management
  Resignation of Mr Himanshu Ranvah as Other of the company w.e.f. February 06, 2026. (opens in a new tab)
- 5 Feb · Management
  Change in Senior Management Personnel - Resignation (opens in a new tab)
- 5 Feb · Management
  Resignation of Mr Dilip Singh Rathore as Other of the company w.e.f. March 05, 2026. (opens in a new tab)
- 5 Feb · Management
  Resignation of Mr Kunal Khanna as Other of the company w.e.f. March 05, 2026. (opens in a new tab)
- 5 Feb · Corporate action
  Intimation of Record Date (opens in a new tab)
- 5 Feb · Board meeting
  Outcome of meeting of the Board of Directors- Declaration of Interim Dividend and Appointment of CFO (opens in a new tab)
- 5 Feb · Corporate action
  Record date for the purpose of Dividend is 11-Feb-2026. (opens in a new tab)
- 5 Feb · Dividend
  Board of Directors at its meeting held on February 05, 2026, declared Interim Dividend of Rs. 12.70 per equity share. (opens in a new tab)
- 5 Feb · Management
  Change in Key Managerial Personnel- Letter of Resignation (opens in a new tab)
- 5 Feb · General Updates
  Change in Key Managerial Personnel - Letter of Resignation (opens in a new tab)
- 4 Feb · Shifting Of Registered Office
  Disclosure under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements Regulations), 2015 (opens in a new tab)
- 4 Feb · Disclosure of material issue
  JB Chemicals & Pharmaceuticals Limited has informed regarding Disclosure Shifting of Registered Office (opens in a new tab)
- 2 Feb · Board meeting
  This is to intimate you that meeting of the Board of Directors of the Company will be held on February 5, 2026, inter alia, to consider declaration of Interim dividend, if any, for the financial year 2025-26. (opens in a new tab)
- 2 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve This is to intimate .... (opens in a new tab)
Jan 2026
- 30 Jan · Disclosure
  Allotment of 92490 Shares. (opens in a new tab)
- 30 Jan · Disclosure
  Allotment of equity shares on exercise of Stock Options pursuant to the Employee Stock Option Scheme (opens in a new tab)
- 29 Jan · Management
  Resignation of Mr Narayan Saraf as Chief Financial Officer of the company w.e.f. January 30, 2026. (opens in a new tab)
- 29 Jan · Management
  Change in Key Managerial Personnel- Resignation of Chief Financial Officer (opens in a new tab)
- 24 Jan · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Torrent Pharmaceuticals Ltd (opens in a new tab)
- 24 Jan · Disclosure
  Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 23, 2026 for Tau Investment Holdings .... (opens in a new tab)
- 22 Jan · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Torrent Pharmaceuticals Ltd (opens in a new tab)
- 22 Jan · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Tau Investment Holdings Pte Ltd (opens in a new tab)
- 21 Jan · General Updates
  Corrigendum to the Outcome of the first Board Meeting held on 21 January 2026 (opens in a new tab)
- 21 Jan · Corrigendum To The Outcome Of The First Board Meeting Held On 21 January 2026
  Corrigendum (opens in a new tab)
- 21 Jan
  General Updates (opens in a new tab)
- 21 Jan · Disclosure Under Regulation 31A(10)(Ii) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations").
  Disclosure under Regulation 31A of LODR (opens in a new tab)
- 21 Jan · Board meeting
  Outcome of Board Meeting held on January 21, 2026. (opens in a new tab)